Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T31299
|
|||||
Target Name |
HLA-A02/AFP complex (HLA-A02/AFP)
|
|||||
Synonyms |
HLA-A2/AFP complex
Click to Show/Hide
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Liver cancer [ICD-11: 2C12] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | Autologous ET1402L1-CART cells | Drug Info | Phase 1 | Hepatocellular carcinoma | [1] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
CAR-T-Cell-Therapy | [+] 1 CAR-T-Cell-Therapy drugs | + | ||||
1 | Autologous ET1402L1-CART cells | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03349255) Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.